AU2003255248A1 - Real-time monitoring of factors relating to transmissible spongiform encephalopathies - Google Patents

Real-time monitoring of factors relating to transmissible spongiform encephalopathies

Info

Publication number
AU2003255248A1
AU2003255248A1 AU2003255248A AU2003255248A AU2003255248A1 AU 2003255248 A1 AU2003255248 A1 AU 2003255248A1 AU 2003255248 A AU2003255248 A AU 2003255248A AU 2003255248 A AU2003255248 A AU 2003255248A AU 2003255248 A1 AU2003255248 A1 AU 2003255248A1
Authority
AU
Australia
Prior art keywords
real
time monitoring
spongiform encephalopathies
factors relating
transmissible spongiform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255248A
Other versions
AU2003255248A8 (en
Inventor
Thomas A. Casey
Ricky Lee Flick
Albin H. Gapsch
Jacob W. Petrich
Mark A. Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iowa State University Research Foundation ISURF
US Department of Agriculture USDA
EMerge Interactive Inc
Original Assignee
EMerge Interactive Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMerge Interactive Inc filed Critical EMerge Interactive Inc
Publication of AU2003255248A1 publication Critical patent/AU2003255248A1/en
Publication of AU2003255248A8 publication Critical patent/AU2003255248A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/407—Evaluating the spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N2021/6417—Spectrofluorimetric devices
AU2003255248A 2002-08-09 2003-08-08 Real-time monitoring of factors relating to transmissible spongiform encephalopathies Abandoned AU2003255248A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40214402P 2002-08-09 2002-08-09
US60/402,144 2002-08-09
US41297002P 2002-09-23 2002-09-23
US60/412,970 2002-09-23
PCT/US2003/025035 WO2004014229A1 (en) 2002-08-09 2003-08-08 Real-time monitoring of factors relating to transmissible spongiform encephalopathies

Publications (2)

Publication Number Publication Date
AU2003255248A1 true AU2003255248A1 (en) 2004-02-25
AU2003255248A8 AU2003255248A8 (en) 2004-02-25

Family

ID=31720572

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255248A Abandoned AU2003255248A1 (en) 2002-08-09 2003-08-08 Real-time monitoring of factors relating to transmissible spongiform encephalopathies

Country Status (2)

Country Link
AU (1) AU2003255248A1 (en)
WO (1) WO2004014229A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474910A (en) * 1993-10-15 1995-12-12 Alfano; Robert R. Method and device for detecting biological molecules and/or microorganisms within a desired area or space
US5914247A (en) * 1998-03-03 1999-06-22 The United States Of America As Represented By The Secretary Of Agriculture Method and system for detecting fecal and ingesta contamination on the carcasses of meat animals
US6205354B1 (en) * 1999-06-18 2001-03-20 University Of Utah Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue
DE10065700A1 (en) * 2000-12-29 2002-07-04 Pierre Nicolas Foss Method for documenting state of health of farm animals, especially detecting BSE, comprises computer-controlled non-invasive evaluation of their appearance, neurophysiological and neuromuscular condition using standard tests

Also Published As

Publication number Publication date
WO2004014229A1 (en) 2004-02-19
AU2003255248A8 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
AU2003301347A1 (en) Methods for monitoring treatment of disease
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003233526A1 (en) Real-time notification of presence availability changes
AU2003213008A1 (en) Server self-health monitor
AU2003283169A1 (en) Refrigeration monitor
AU2002363968A1 (en) Methods for fast progressive evaluation of polynomial range-sum queries on real-time datacubes
AU2003210829A1 (en) Battery-powered wristwatch
AU2003216296A1 (en) Reducing the susceptibility of titanium nitride optical layers to crack
AU2003202047A1 (en) Monitoring of network usage
AU2003214112A1 (en) Salts of nateglinide
AU2003232398A1 (en) Sustained release oral dosage forms of gabapentin
AU2003215781A1 (en) Method for production of phytoalexins
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2003205687A1 (en) Process for the coloration of aluminium
AU2003266397A1 (en) Method for the production of polyisobutene
AU2002342816A1 (en) Interferometer monitoring
AU2003236243A1 (en) Novel nateglinide crystal
AU2003255248A1 (en) Real-time monitoring of factors relating to transmissible spongiform encephalopathies
AU2003290320A1 (en) Threaded bolt fastener
AU2003270399A1 (en) Management of information relating to construction industry products
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003202872A1 (en) Preparation of nano-sized crystals
AU2003266709A1 (en) Method of coagulating poly-3-hydroxyalkanoic acid
AU2002356423A1 (en) Process for the preparation of amorphous atorvastatin calcium
AU2003217438A1 (en) Novel crystalline forms of levetiracetam

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase